Quick Answer
Black Seed Immune Support Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Quality assessment, including risk of bias, was performed using the Jadad checklist.
Key Takeaways
- 01Quality assessment, including risk of bias, was performed using the Jadad checklist. [Dashti S (2026)]
- 02BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and one of the important causes of infertility due to a lack of ovulation. [Dashti S (2026)]
- 03OBJECTIVE: Given the consideration of herbal medicines in the treatment of this condition, this systematic review was conducted to investigate the effect of herbal compounds on the treatment of PCOS. [Dashti S (2026)]
- 04Preclinical evidence suggests that CBD modulates endocannabinoid and serotonergic signaling, potentially contributing to the regulation of physiological processes associated with hyperarousal. [Kovitkanit P (2026)]
The current Migaku evidence database contains 2 reusable source documents for Black Seed Immune Support Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- Quality assessment, including risk of bias, was performed using the Jadad checklist. [Dashti S (2026); evidence level 1]
- BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and one of the important causes of infertility due to a lack of ovulation. [Dashti S (2026); evidence level 1]
- OBJECTIVE: Given the consideration of herbal medicines in the treatment of this condition, this systematic review was conducted to investigate the effect of herbal compounds on the treatment of PCOS. [Dashti S (2026); evidence level 1]
- Preclinical evidence suggests that CBD modulates endocannabinoid and serotonergic signaling, potentially contributing to the regulation of physiological processes associated with hyperarousal. [Kovitkanit P (2026); evidence level 4]
- However, the current evidence base is predominantly preclinical, and definitive conclusions regarding therapeutic efficacy or optimal dosing in humans remain limited. [Kovitkanit P (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources